| Outgoing Relation(s) |
| glycosphingolipid (CHEBI:24402) is a glycolipid (CHEBI:33563) |
| glycosphingolipid (CHEBI:24402) is a sphingolipid (CHEBI:26739) |
| Incoming Relation(s) |
| (3R,4S,5S,6R)-2-{[(4E)-2-amino-3-hydroxyoctadec-4-en-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol (CHEBI:185325) is a glycosphingolipid (CHEBI:24402) |
| N-[(2S,3S,4R)-1-(α-D-galactosyloxy)-3,4-dihydroxyoctadecan-2-yl]hexacosanethioamide (CHEBI:86510) is a glycosphingolipid (CHEBI:24402) |
| N-acetyl-β-D-glucosaminyl-(1→3)-[N-acetyl-β-D-galactosaminyl-(1→4)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide (CHEBI:142962) is a glycosphingolipid (CHEBI:24402) |
| N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide (CHEBI:142587) is a glycosphingolipid (CHEBI:24402) |
| SO3-6-O-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(1−) (CHEBI:142964) is a glycosphingolipid (CHEBI:24402) |
| 3-O-Sulfogalactosylceramide (d18:1/18:0) (CHEBI:191473) is a glycosphingolipid (CHEBI:24402) |
| acidic glycosphingolipid (CHEBI:36526) is a glycosphingolipid (CHEBI:24402) |
| Allantoside (CHEBI:220317) is a glycosphingolipid (CHEBI:24402) |
| Alpha-D-Galactouronosylceramide II (CHEBI:217422) is a glycosphingolipid (CHEBI:24402) |
| Araliacerebroside (CHEBI:183035) is a glycosphingolipid (CHEBI:24402) |
| artificial glycosphingolipid (CHEBI:190304) is a glycosphingolipid (CHEBI:24402) |
| Asperiamide B (CHEBI:219269) is a glycosphingolipid (CHEBI:24402) |
| Catacerebroside B (CHEBI:217346) is a glycosphingolipid (CHEBI:24402) |
| Catacerebroside C (CHEBI:217453) is a glycosphingolipid (CHEBI:24402) |
| Cerebroside 1 (CHEBI:229076) is a glycosphingolipid (CHEBI:24402) |
| Culinariside (CHEBI:169852) is a glycosphingolipid (CHEBI:24402) |
| Deformin (CHEBI:199835) is a glycosphingolipid (CHEBI:24402) |
| Fucalpha1-3(Galbeta1-4)GlcNAcbeta1-6Galbeta1-4Glc-ceramide (CHEBI:234964) is a glycosphingolipid (CHEBI:24402) |
| Fucalpha1-3GlcNAcbeta1-6Galbeta1-4Glc-ceramide (CHEBI:235296) is a glycosphingolipid (CHEBI:24402) |
| Galactosylceramide (d18:1/18:0) (CHEBI:191324) is a glycosphingolipid (CHEBI:24402) |
| Galactosylceramide (d18:1/20:0) (CHEBI:191340) is a glycosphingolipid (CHEBI:24402) |
| Galalpha1-3Galbeta1-4GalNAcbeta1-3Galbeta1-4Glc-ceramide (CHEBI:235299) is a glycosphingolipid (CHEBI:24402) |
| Galb1-4GalNAcbeta1-3Galbeta1-4Glc-ceramide (CHEBI:234799) is a glycosphingolipid (CHEBI:24402) |
| Galbeta1-4Galbeta1-4Glc-ceramide (CHEBI:235294) is a glycosphingolipid (CHEBI:24402) |
| Galbeta1-4GlcNAcbeta1-6Galbeta1-4Glc-ceramide (CHEBI:235186) is a glycosphingolipid (CHEBI:24402) |
| GalNAcbeta1-3Galbeta1-4Glc-ceramide (CHEBI:234902) is a glycosphingolipid (CHEBI:24402) |
| GalNAcbeta1-4Galbeta1-4GalNAcbeta1-3Galbeta1-4Glc-ceramide (CHEBI:235197) is a glycosphingolipid (CHEBI:24402) |
| ganglioside (CHEBI:28892) is a glycosphingolipid (CHEBI:24402) |
| Ganglioside GA2 (d18:1/12:0) (CHEBI:192101) is a glycosphingolipid (CHEBI:24402) |
| Ganglioside GD2 (d18:1/25:0) (CHEBI:177822) is a glycosphingolipid (CHEBI:24402) |
| Ganglioside GM3 (d18:1/9Z-18:1) (CHEBI:230374) is a glycosphingolipid (CHEBI:24402) |
| GlcAbeta-Cer(d18:1/18:0) (CHEBI:183140) is a glycosphingolipid (CHEBI:24402) |
| GlcCer d42:1 (CHEBI:190674) is a glycosphingolipid (CHEBI:24402) |
| GlcCer d42:2 (CHEBI:190675) is a glycosphingolipid (CHEBI:24402) |
| GlcCer(d18:0/16:0(2OH[R])) (CHEBI:183033) is a glycosphingolipid (CHEBI:24402) |
| GlcCer(d18:1(8Z)/16:0(2OH[R])) (CHEBI:183023) is a glycosphingolipid (CHEBI:24402) |
| GlcNAcbeta1-3Manbeta1-4Glc-ceramide (CHEBI:235335) is a glycosphingolipid (CHEBI:24402) |
| GlcNAcbeta1-6Galbeta1-4Glc-ceramide (CHEBI:235151) is a glycosphingolipid (CHEBI:24402) |
| GlcNAcβ1-4Manβ1-4Glc-ceramide (CHEBI:234616) is a glycosphingolipid (CHEBI:24402) |
| globoside (CHEBI:61360) is a glycosphingolipid (CHEBI:24402) |
| glycosylceramide (CHEBI:62941) is a glycosphingolipid (CHEBI:24402) |
| HSO3-3Galalpha1-4Gal-ceramide (CHEBI:234736) is a glycosphingolipid (CHEBI:24402) |
| isogloboside (CHEBI:78257) is a glycosphingolipid (CHEBI:24402) |
| KDNalpha2-3Galbeta1-4Glc-ceramide (CHEBI:234718) is a glycosphingolipid (CHEBI:24402) |
| LacCer(d18:0/14:0) (CHEBI:183135) is a glycosphingolipid (CHEBI:24402) |
| Lacto-series glycosphingolipid (CHEBI:183224) is a glycosphingolipid (CHEBI:24402) |
| Lucyobroside (CHEBI:169916) is a glycosphingolipid (CHEBI:24402) |
| lyso-GM2 (CHEBI:141464) is a glycosphingolipid (CHEBI:24402) |
| Manalpha1-3Manbeta1-4Glc-ceramide (CHEBI:234615) is a glycosphingolipid (CHEBI:24402) |
| Manβ1-4Glc-ceramide (CHEBI:234614) is a glycosphingolipid (CHEBI:24402) |
| N-[(2S,3S)-3-Hydroxy-1-{[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}nonadecan-2-yl]octadecanimidic acid (CHEBI:185427) is a glycosphingolipid (CHEBI:24402) |
| neoglycosphingolipid (CHEBI:51021) is a glycosphingolipid (CHEBI:24402) |
| Neolacto-series glycosphingolipid (CHEBI:183225) is a glycosphingolipid (CHEBI:24402) |
| NeuAcalpha2-3Galb1-4GalNAcbeta1-3Galbeta1-4Glc-ceramide (CHEBI:234800) is a glycosphingolipid (CHEBI:24402) |
| NeuAcalpha2-8NeuGcalpha2-3Galbeta1-4Glc-ceramide (CHEBI:235302) is a glycosphingolipid (CHEBI:24402) |
| NeuGcalpha2-3Galbeta1-4Glc-ceramide (CHEBI:234987) is a glycosphingolipid (CHEBI:24402) |
| neutral glycosphingolipid (CHEBI:25513) is a glycosphingolipid (CHEBI:24402) |
| oceanalin A (CHEBI:66806) is a glycosphingolipid (CHEBI:24402) |
| psychosine 3-sulfate zwitterion (CHEBI:229754) is a glycosphingolipid (CHEBI:24402) |
| Trihexosylceramide (d18:1/16:0) (CHEBI:230300) is a glycosphingolipid (CHEBI:24402) |
